Article
Genetic basis for personalized medicine in asthma
28 Mar 2012
Abstract excerpt
There is heterogeneity in patient responses to current asthma medications. Significant progress has been made identifying genetic polymorphisms that influence the efficacy and potential for adverse effects to asthma drugs, including; β(2)-adrenergic receptor agonists, corticosteroids and leukotriene modifiers. Pharmacogenetics holds great promise to maximise clinical outcomes and minimize adverse effects. Asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
